|
1
|
Wang M, Liang Y, Chen K, Wang M, Long X,
Liu H, Sun Y and He B: The management of diabetes mellitus by
mangiferin: Advances and prospects. Nanoscale. 14:2119–2135. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bhattacharyya S, Ahmmed SM, Saha BP and
Mukherjee PK: Soya phospholipid complex of mangiferin enhances its
hepatoprotectivity by improving its bioavailability and
pharmacokinetics. J Sci Food Agric. 94:1380–1388. 2014. View Article : Google Scholar
|
|
3
|
Mei S, Perumal M, Battino M, Kitts DD,
Xiao J, Ma H and Chen X: Mangiferin: A review of dietary sources,
absorption, metabolism, bioavailability, and safety. Crit Rev Food
Sci Nutr. 63:3046–3064. 2023. View Article : Google Scholar
|
|
4
|
Morozkina SN, Nhung Vu TH, Generalova YE,
Snetkov PP and Uspenskaya MV: Mangiferin as new potential
anti-cancer agent and mangiferin-integrated polymer systems-a novel
research direction. Biomolecules. 11:792021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang M, Zhang Z, Huo Q, Wang M, Sun Y, Liu
H, Chang J, He B and Liang Y: Targeted polymeric nanoparticles
based on mangiferin for enhanced protection of pancreatic β-cells
and type 1 diabetes mellitus efficacy. ACS Appl Mater Interfaces.
14:11092–11103. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Akkewar AS, Mishra KA and Sethi KK:
Mangiferin: A natural bioactive immunomodulating glucosylxanthone
with potential against cancer and rheumatoid arthritis. J Biochem
Mol Toxicol. 38:e237652024. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yehia RS and Altwaim SA: An insight into
in vitro antioxidant, antimicrobial, cytotoxic, and apoptosis
induction potential of mangiferin, a bioactive compound derived
from mangifera indica. Plants (Basel). 12:15392023.PubMed/NCBI
|
|
8
|
Xiang G, Guo S, Xing N, Du Q, Qin J, Gao
H, Zhang Y and Wang S: Mangiferin, a potential supplement to
improve metabolic syndrome: Current status and future
opportunities. Am J Chin Med. 52:355–386. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li HW, Lan TJ, Yun CX, Yang KD, Du ZC, Luo
XF, Hao EW and Deng JG: Mangiferin exerts neuroprotective activity
against lead-induced toxicity and oxidative stress via Nrf2
pathway. Chin Herb Med. 12:36–46. 2020.
|
|
10
|
Aritomi M and Kawasaki T: A new xanthone
C-glucoside, position isomer of mangiferin, from anemarrhena
asphodeloides bunge. Tetrahedron Lett. 12:941–944. 1969. View Article : Google Scholar
|
|
11
|
Talamond P, Conejero GV, Verdeil JL and
Poëssel JL: Isolation of C-glycosyl xanthones from coffea
pseudozanguebariae and their location. Nat Prod Commun.
6:1885–1888. 2011.
|
|
12
|
Vyas A, Syeda K, Ahmad A, Padhye S and
Sarkar FH: Perspectives on medicinal properties of mangiferin. Mini
Rev Med Chem. 12:412–425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du S, Liu H, Lei T, Xie X, Wang H, He X,
Tong R and Wang Y: Mangiferin: An effective therapeutic agent
against several disorders (review). Mol Med Rep. 18:4775–4786.
2018.PubMed/NCBI
|
|
14
|
Kavitha M, Nataraj J, Essa MM, Memon MA
and Manivasagam T: Mangiferin attenuates MPTP induced dopaminergic
neurodegeneration and improves motor impairment, redox balance and
bcl-2/bax expression in experimental Parkinson's disease mice. Chem
Biol Interact. 206:239–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hudecová A, Kusznierewicz B, Hašplová K,
Huk A, Magdolenová Z, Miadoková E, Gálová E and Dušinská M:
Gentiana asclepiadea exerts antioxidant activity and enhances DNA
repair of hydrogen peroxide- and silver nanoparticles-induced DNA
damage. Food Chem Toxicol. 50:3352–3359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Andreu GP, Delgado R, Velho JA, Curti C
and Vercesi AE: Iron complexing activity of mangiferin, a naturally
occurring glucosylxanthone, inhibits mitochondrial lipid
peroxidation induced by Fe2+-citrate. Eur J Pharmacol. 513:47–55.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gu PC, Wang L, Han MN, Peng J, Shang JC,
Pan YQ and Han WL: Comparative pharmacokinetic study of mangiferin
in normal and alloxan-induced diabetic rats after oral and
intravenous administration by UPLC-MS/MS. Pharmacology. 103:30–37.
2019. View Article : Google Scholar
|
|
18
|
Liu H, Wu B, Pan G, He L, Li Z, Fan M,
Jian L, Chen M, Wang K and Huang C: Metabolism and pharmacokinetics
of mangiferin in conventional rats, pseudo-germ-free rats, and
streptozotocin-induced diabetic rats. Drug Metab Dispos.
40:2109–2118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gelabert-Rebato M, Wiebe JC, Martin-Rincon
M, Gericke N, Perez-Valera M, Curtelin D, Galvan-Alvarez V,
Lopez-Rios L, Morales-Alamo D and Calbet JAL: Mangifera indica l.
Leaf extract in combination with luteolin or quercetin enhances
VO2peak and peak power output, and preserves skeletal muscle
function during ischemia-reperfusion in humans. Front Physiol.
9:7402018. View Article : Google Scholar :
|
|
20
|
Ehianeta TS, Laval SP and Yu B: Bio- and
chemical syntheses of mangiferin and congeners. Biofactors.
42:445–458. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tian X, Gao Y, Xu Z, Lian S, Ma Y, Guo X,
Hu P, Li Z and Huang C: Pharmacokinetics of mangiferin and its
metabolite-norathyriol, part 1: Systemic evaluation of hepatic
first-pass effect in vitro and in vivo. Biofactors. 42:533–544.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hasanah U, Miki K, Nitoda T and Kanzaki H:
Aerobic bioconversion of c-glycoside mangiferin into its aglycone
norathyriol by an isolated mouse intestinal bacterium. Biosci
Biotechnol Biochem. 85:989–997. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Jafari SM, Zhou F, Hong H, Jia X,
Mei X, Hou G, Yuan Y, Liu B, Chen S, et al: The intracellular fate
and transport mechanism of shape, size and rigidity varied
nanocarriers for understanding their oral delivery efficiency.
Biomaterials. 294:1219952023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Furlanetto V, Kalyani DC, Kostelac A, Puc
J, Haltrich D, Hällberg BM and Divne C: Structural and functional
characterization of a gene cluster responsible for deglycosylation
of C-glucosyl flavonoids and xanthonoids by deinococcus aerius. J
Mol Biol. 436:1685472024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pereira QC, Fortunato IM, Oliveira FS,
Alvarez MC, Santos TWD and Ribeiro ML: Polyphenolic compounds:
Orchestrating intestinal microbiota harmony during aging.
Nutrients. 16:10662024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaur P, Gupta RC, Dey A, Malik T and
Pandey DK: Optimization of harvest and extraction factors by full
factorial design for the improved yield of C-glucosyl xanthone
mangiferin from swertia chirata. Sci Rep. 11:163462021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suman RK, Borde MK, Mohanty IR and Singh
HK: Mechanism of action of natural dipeptidyl peptidase-IV
inhibitors (berberine and mangiferin) in experimentally induced
diabetes with metabolic syndrome. Int J Appl Basic Med Res.
13:133–142. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shimada T, Nagai E, Harasawa Y, Watanabe
M, Negishi K, Akase T, Sai Y, Miyamoto K and Aburada M: Salacia
reticulata inhibits differentiation of 3T3-l1 adipocytes. J
Ethnopharmacol. 136:67–74. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mao X, Liu L, Cheng L, Cheng R, Zhang L,
Deng L, Sun X, Zhang Y, Sarmento B and Cui W: Adhesive
nanoparticles with inflammation regulation for promoting skin flap
regeneration. J Control Release. 297:91–101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang CQ, Xu JH, Yan DD, Liu BL, Liu K and
Huang F: Mangiferin ameliorates insulin resistance by inhibiting
inflammation and regulatiing adipokine expression in adipocytes
under hypoxic condition. Chin J Nat Med. 15:664–673.
2017.PubMed/NCBI
|
|
31
|
Fan X, Jiao G, Pang T, Wen T, He Z, Han J,
Zhang F and Chen W: Ameliorative effects of mangiferin derivative
TPX on insulin resistance via PI3k/AKT and AMPK signaling pathways
in human HepG2 and HL-7702 hepatocytes. Phytomedicine.
114:1547402023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han J, Yi J, Liang F, Jiang B, Xiao Y, Gao
S, Yang N, Hu H, Xie WF and Chen W: X-3, a mangiferin derivative,
stimulates AMP-activated protein kinase and reduces hyperglycemia
and obesity in db/db mice. Mol Cell Endocrinol. 405:63–73. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fu TL, Li GR, Li DH, He RY, Liu BH, Xiong
R, Xu CZ, Lu ZL, Song CK, Qiu HL, et al: Mangiferin alleviates
diabetic pulmonary fibrosis in mice via inhibiting
endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis.
Acta Pharmacol Sin. 45:1002–1018. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Song Y, Liu W, Tang K, Zang J, Li D and
Gao H: Mangiferin alleviates renal interstitial fibrosis in
streptozotocin-induced diabetic mice through regulating the
PTEN/PI3k/Akt signaling pathway. J Diabetes Res. 2020:94817202020.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shivam and Gupta AK: Neuroprotective
effects of isolated mangiferin from swertia chirayita leaves
regulating oxidative pathway on streptozotocin-induced diabetic
neuropathy in experimental rats. Cent Nerv Syst Agents Med Chem.
24:182–195. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Iqbal H, Inam-Ur-Raheem M, Munir S, Rabail
R, Kafeel S, Shahid A, Mousavi Khaneghah A and Aadil RM:
Therapeutic potential of mangiferin in cancer: unveiling regulatory
pathways, mechanisms of action, and bioavailability enhancements-an
updated review. Food Sci Nutr. 12:1413–1429. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiao J, Liu L, Zhong Z, Xiao C and Zhang
J: Mangiferin regulates proliferation and apoptosis in glioma cells
by induction of microRNA-15b and inhibition of MMP-9 expression.
Oncol Rep. 33:2815–2820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gold-Smith F, Fernandez A and Bishop K:
Mangiferin and cancer: Mechanisms of action. Nutrients. 8:3962016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rahmani AH, Almatroudi A, Allemailem KS,
Alharbi HOA, Alwanian WM, Alhunayhani BA, Algahtani M, Theyab A,
Almansour NM, Algefary AN, et al: Role of mangiferin in management
of cancers through modulation of signal transduction pathways.
Biomedicines. 11:32052023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Takeda T, Tsubaki M, Sakamoto K, Ichimura
E, Enomoto A, Suzuki Y, Itoh T, Imano M, Tanabe G, Muraoka O, et
al: Mangiferin, a novel nuclear factor kappa b-inducing kinase
inhibitor, suppresses metastasis and tumor growth in a mouse
metastatic melanoma model. Toxicol Appl Pharmacol. 306:105–112.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jung JS, Jung K, Kim DH and Kim HES:
Selective inhibition of MMP-9 gene expression by mangiferin in
PMA-stimulated human astroglioma cells: involvement of PI3k/akt and
MAPK signaling pathways. Pharmacol Res. 66:95–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dilshara MG, Kang CH, Choi YH and Kim GY:
Mangiferin inhibits tumor necrosis factor-α-induced matrix
metalloproteinase-9 expression and cellular invasion by suppressing
nuclear factor-κB activity. BMB Rep. 48:559–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shoji K, Tsubaki M, Yamazoe Y, Satou T,
Itoh T, Kidera Y, Tanimori Y, Yanae M, Matsuda H, Taga A, et al:
Mangiferin induces apoptosis by suppressing Bcl-xL and XIAP
expressions and nuclear entry of NF-κB in HL-60 cells. Arch Pharm
Res. 34:469–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gong M, Li Y, Ye X, Zhang L, Wang Z, Xu X,
Shen Y and Zheng C: Loss-of-function mutations in KEAP1 drive lung
cancer progression via KEAP1/NRF2 pathway activation. Cell Commun
Signal. 18:982020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
DeBlasi JM, Falzone A, Caldwell S,
Prieto-Farigua N, Prigge JR, Schmidt EE, Chio IIC, Karreth FA and
DeNicola GM: Distinct nrf2 signaling thresholds mediate lung tumor
initiation and progression. Cancer Res. 83:1953–1967. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pal PB, Sinha K and Sil PC: Mangiferin
attenuates diabetic nephropathy by inhibiting oxidative stress
mediated signaling cascade, TNFα related and mitochondrial
dependent apoptotic pathways in streptozotocin-induced diabetic
rats. PLoS One. 9:e1072202014. View Article : Google Scholar
|
|
47
|
Du M, Wen G, Jin J, Chen Y, Cao J and Xu
A: Mangiferin prevents the growth of gastric carcinoma by blocking
the PI3K-Akt signalling pathway. Anticancer Drugs. 29:167–175.
2018. View Article : Google Scholar
|
|
48
|
Zou B, Wang H, Liu Y, Qi P, Lei T, Sun M
and Wang Y: Mangiferin induces apoptosis in human ovarian
adenocarcinoma OVCAR3 cells via the regulation of Notch3. Oncol
Rep. 38:1431–1441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xia J, Li X, Yao J, Song D, Gu Z, Zheng G
and Tu C: Mangiferin targets PFKFB3 to inhibit glioblastoma
progression by suppressing glycolysis and PI3k/AKT/mTOR signaling.
Brain Res Bull. 230:1115202025. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Girón MD, Sevillano N, Salto R, Haidour A,
Manzano M, Jiménez ML, Rueda R and López-Pedrosa JM: Salacia
oblonga extract increases glucose transporter 4-mediated glucose
uptake in L6 rat myotubes: Role of mangiferin. Clin Nutr.
28:565–574. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Apontes P, Liu Z, Su K, Benard O, Youn DY,
Li X, Li W, Mirza RH, Bastie CC, Jelicks LA, et al: Mangiferin
stimulates carbohydrate oxidation and protects against metabolic
disorders induced by high-fat diets. Diabetes. 63:3626–3636. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Singh AK, Raj V, Keshari AK, Rai A, Kumar
P, Rawat A, Maity B, Kumar D, Prakash A, De A, et al: Isolated
mangiferin and naringenin exert antidiabetic effect via
PPAR(γ)/GLUT4 dual agonistic action with strong metabolic
regulation. Chem Biol Interact. 280:33–44. 2018. View Article : Google Scholar
|
|
53
|
Mistry J, Biswas M, Sarkar S and Ghosh S:
Antidiabetic activity of mango peel extract and mangiferin in
alloxan-induced diabetic rats. Future J Pharm. 9:222023. View Article : Google Scholar
|
|
54
|
Alsaedi AQ, Nader MA, El-Kashef DH and
Abdelmageed ME: Mangiferin mitigates dexamethasone-induced insulin
resistance in rats: Insight into vascular dysfunction and hepatic
steatosis. Front Pharmacol. 16:15727582025. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Żuryń A, Krajewski A, Szulc D, Litwiniec A
and Grzanka A: Activity of cyclin B1 in HL-60 cells treated with
etoposide. Acta Histochem. 118:537–543. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Shi W, Deng J, Tong R, Yang Y, He X, Lv J,
Wang H, Deng S, Qi P, Zhang D and Wang Y: Molecular mechanisms
underlying mangiferin-induced apoptosis and cell cycle arrest in
A549 human lung carcinoma cells. Mol Med Rep. 13:3423–3432. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Pal-Ghosh R, Xue D, Warburton R, Hill N,
Polgar P and Wilson JL: CDC2 is an important driver of vascular
smooth muscle cell proliferation via FOXM1 and PLK1 in pulmonary
arterial hypertension. Int J Mol Sci. 22:69432021. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gonnella R, Zarrella R, Di Crosta M,
Benedetti R, Arena A, Santarelli R, Gilardini Montani MS, D'Orazi G
and Cirone M: HSP110 inhibition in primary effusion lymphoma cells:
One molecule, many pro-survival targets. Cancers (Basel).
15:56512023. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Huysentruyt J, Steels W, Ruiz Perez M,
Verstraeten B, Vadi M, Divert T, Flies K, Takahashi N, Lambrecht
BN, Declercq W, et al: RIPK1 protects naive and regulatory T cells
from TNFR1-induced apoptosis. Cell Death Differ. 31:820–832. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Liu Z, Li Y, Zhu Y, Li N, Li W, Shang C,
Song G, Li S, Cong J, Li T, et al: Apoptin induces pyroptosis of
colorectal cancer cells via the GSDME-dependent pathway. Int J Biol
Sci. 18:717–730. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Pan LL, Wang AY, Huang YQ, Luo Y and Ling
M: Mangiferin induces apoptosis by regulating Bcl-2 and bax
expression in the CNE2 nasopharyngeal carcinoma cell line. Asian
Pac J Cancer Prev. 15:7065–7068. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Kim H, Kim H, Mosaddik A, Gyawali R, Ahn
KS and Cho SK: Induction of apoptosis by ethanolic extract of mango
peel and comparative analysis of the chemical constitutes of mango
peel and flesh. Food Chem. 133:416–422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Budakoti M, Panwar AS, Molpa D, Singh RK,
Busselberg D, Mishra AP, Coutinho HDM and Nigam M: Micro-RNA: The
darkhorse of cancer. Cell Signal. 83:1099952021. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Maclean JA II, King ML, Okuda H and
Hayashi K: WNT7a regulation by mir-15b in ovarian cancer. PLoS One.
11:e01561092016. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Li M, Ma H, Yang L and Li P: Mangiferin
inhibition of proliferation and induction of apoptosis in human
prostate cancer cells is correlated with downregulation of b-cell
lymphoma-2 and upregulation of microRNA-182. Oncol Lett.
11:817–822. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Chi XJ, Meng JJ, Lin CY, Su QS, Qin YY,
Wei RH, Lan D and Huang C: Mangiferin inhibits human lung
adenocarcinoma by suppressing MiR-27b and MiR-92a. Evid Based
Complement Alternat Med. 2021:28229502021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Green DR: The mitochondrial pathway of
apoptosis: Part I: MOMP and beyond. Cold Spring Harb Perspect Biol.
14:a0410382022. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bhat TA, Chaudhary AK, Kumar S, O'Malley
J, Inigo JR, Kumar R, Yadav N and Chandra D: Endoplasmic
reticulum-mediated unfolded protein response and mitochondrial
apoptosis in cancer. Biochim Biophys Acta Rev Cancer. 1867:58–66.
2017. View Article : Google Scholar
|
|
69
|
Rodriguez-Gonzalez JC, Hernández-Balmaseda
I, Declerck K, Pérez-Novo C, Logie E, Theys C, Jakubek P,
Quiñones-Maza OL, Dantas-Cassali G, Carlos Dos Reis D, et al:
Antiproliferative, antiangiogenic, and antimetastatic therapy
response by mangiferin in a syngeneic immunocompetent colorectal
cancer mouse model involves changes in mitochondrial energy
metabolism. Front Pharmacol. 12:6701672021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Rajendran P, Ekambaram G and Sakthisekaran
D: Effect of mangiferin on benzo(a)pyrene induced lung
carcinogenesis in experimental swiss albino mice. Nat Prod Res.
22:672–680. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Tang Z, Lai CC, Luo J, Ding YT, Chen Q and
Guan ZZ: Mangiferin prevents the impairment of mitochondrial
dynamics and an increase in oxidative stress caused by excessive
fluoride in SH-SY5Y cells. J Biochem Mol Toxicol. 35:e227052021.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Hajam YA, Rani R, Ganie SY, Sheikh TA,
Javaid D, Qadri SS, Pramodh S, Alsulimani A, Alkhanani MF, Harakeh
S, et al: Oxidative stress in human pathology and aging: molecular
mechanisms and perspectives. Cells. 11:5522022. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ren J, Su D, Li L, Cai H, Zhang M, Zhai J,
Li M, Wu X and Hu K: Anti-inflammatory effects of aureusidin in
LPS-stimulated RAW264.7 macrophages via suppressing NF-κB and
activating ROS- and MAPKs-dependent Nrf2/HO-1 signaling pathways.
Toxicol Appl Pharmacol. 387:1148462020. View Article : Google Scholar
|
|
74
|
Qin ZZ, Ruan J, Lee MR, Sun K, Chen P,
Chen Y, Hong M, Xia LH, Fang J and Tang H: Mangiferin promotes
bregs level, activates Nrf2 antioxidant signaling, and inhibits
proinflammatory cytokine expression in murine splenic mononuclear
cells in vitro. Curr Med Sci. 41:454–464. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zhao J, Zhang B, Li S, Zeng L, Chen Y and
Fang J: Mangiferin increases nrf2 protein stability by inhibiting
its ubiquitination and degradation in human HL60 myeloid leukemia
cells. Int J Mol Med. 33:1348–1354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Kavitha M, Manivasagam T, Essa MM,
Tamilselvam K, Selvakumar GP, Karthikeyan S, Thenmozhi JA and
Subash S: Mangiferin antagonizes rotenone: induced apoptosis
through attenuating mitochondrial dysfunction and oxidative stress
in SK-N-SH neuroblastoma cells. Neurochem Res. 39:668–676. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Walia V, Chaudhary SK and Kumar Sethiya N:
Therapeutic potential of mangiferin in the treatment of various
neuropsychiatric and neurodegenerative disorders. Neurochem Int.
143:1049392021. View Article : Google Scholar
|
|
78
|
Rui R, Zhou L and He S: Cancer
immunotherapies: Advances and bottlenecks. Front Immunol.
14:12124762023. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Yang G, Shang X, Cui G, Zhao L, Zhao H and
Wang N: Mangiferin attenuated diethynitrosamine-induced
hepatocellular carcinoma in sprague-dawley rats via alteration of
oxidative stress and apoptotic pathway. J Environ Pathol Toxicol
Oncol. 38:1–12. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Abdul-Aziz Ahmed K, Jabbar AAJ, Abdulla
MA, Zuhair Alamri Z, Ain Salehen N, Abdel Aziz Ibrahim I, Almaimani
G, Bamagous GA, Almaimani RA, Almasmoum HA, et al: Mangiferin
(mango) attenuates AOM-induced colorectal cancer in rat's colon by
augmentation of apoptotic proteins and antioxidant mechanisms. Sci
Rep. 14:8132024. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Padma VV, Kalaiselvi P, Yuvaraj R and
Rabeeth M: Mangiferin induces cell death against rhabdomyosarcoma
through sustained oxidative stress. Integr Med Res. 4:66–75. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Song J, Li Y, Song J, Hou F, Liu B and Li
A: Mangiferin protects mitochondrial function by preserving
mitochondrial hexokinase-II in vessel endothelial cells. Biochim
Biophys Acta Mol Basis Dis. 1863:1829–1839. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Imran M, Arshad MS, Butt MS, Kwon JH,
Arshad MU and Sultan MT: Mangiferin: A natural miracle bioactive
compound against lifestyle related disorders. Lipids Health Dis.
16:842017. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Trachootham D, Alexandre J and Huang P:
Targeting cancer cells by ROS-mediated mechanisms: A radical
therapeutic approach? Nat Rev Drug Discov. 8:579–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Ismail MB, Rajendran P, Abuzahra HM and
Veeraraghavan VP: Mangiferin inhibits apoptosis in
doxorubicin-induced vascular endothelial cells via the Nrf2
signaling pathway. Int J Mol Sci. 22:42592021. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Kucharczyk K, Florczak A, Kaminska A,
Guzniczak N, Sikorska A, Deptuch T and Dams-Kozlowska H:
MMPs-responsive silk spheres for controlled drug release within
tumor microenvironment. Int J Biol Macromol. 269:1320162024.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Chen J, Liu Z, Fang H, Su Q, Fan Y, Song L
and He S: Therapeutic efficacy of a novel self-assembled
immunostimulatory siRNA combining apoptosis promotion with RIG-I
activation in gliomas. J Transl Med. 22:3952024. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Gálvez-Rodríguez A, Ferino-Pérez A,
Rodríguez-Riera Z, Guerra IR and Jáuregui-Haza UJ: In silico
evaluation of new mangiferin-based positron emission tomography
radiopharmaceuticals through the inhibition of metalloproteinase-9.
J Mol Graph Model. 124:1085692023. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Delgado-Hernández R, Hernández-Balmaseda
I, Rodeiro-Guerra I, Cesar Rodriguez Gonzalez J, De Wever O, Logie
E, Declerck K, Pérez-Novo C and Vanden Berghe W: Anti-angiogenic
effects of mangiferin and mechanism of action in metastatic
melanoma. Melanoma Res. 30:39–51. 2020. View Article : Google Scholar
|
|
90
|
Prata C, Angeloni C and Maraldi T:
Strategies to counteract oxidative stress and inflammation in
chronic-degenerative diseases 2.0. Int J Mol Sci. 25:50262024.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Ghodsi A, Hidalgo A and Libreros S: Lipid
mediators in neutrophil biology: Inflammation, resolution and
beyond. Curr Opin Hematol. 31:175–192. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Lu C, Deng S, Liu Y, Yang S, Qin D, Zhang
L, Wang RR and Zhang Y: Inhibition of macrophage MAPK/NF-κB pathway
and th2 axis by mangiferin ameliorates MC903-induced atopic
dermatitis. Int Immunopharmacol. 133:1120382024. View Article : Google Scholar
|
|
93
|
Nilkhet S, Mongkolpobsin K,
Sillapachaiyaporn C, Wongsirojkul N, Tencomnao T and Chuchawankul
S: M1 macrophages polarized by crude polysaccharides isolated from
auricularia polytricha exhibit anti-tumor effect on human breast
cancer cells. Sci Rep. 14:81792024. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Li SZ, Shu QP, Zhou HM, Liu YY, Fan MQ,
Liang XY, Qi LZ, He YN, Liu XY, Du XH, et al: CLK2 mediates
IκBα-independent early termination of NF-κB activation by inducing
cytoplasmic redistribution and degradation. Nat Commun.
15:39012024. View Article : Google Scholar
|
|
95
|
Wu Y, Yao X, Shi X, Xu Z, Ren J, Shi M, Li
M, Liu J and Du X: Myeloma extracellular vesicle-derived RAGE
increases inflammatory responses and myotube atrophy in multiple
myeloma through activation of the TLR4/NF-κB p65 pathway.
Apoptosis. 29:849–864. 2024. View Article : Google Scholar
|
|
96
|
Cui Y, Li Z, Ni L, Yu S, Shan X, Hu P, Ji
Z, Jing W, Zhou Y, Wang B, et al: Induction of MTHFD2 in
macrophages inhibits reactive oxygen species-mediated NF-κB
activation and protects against inflammatory responses. J Immunol.
212:1345–1356. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zheng M, Liu W, Zhang R, Jiang D, Shi Y,
Wu Y, Ge F and Chen C: E3 ubiquitin ligase BCA2 promotes breast
cancer stemness by up-regulation of SOX9 by LPS. Int J Biol Sci.
20:2686–2697. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Eisa NH, Helmy SA, El-Kashef DH,
El-Sherbiny M and Elsherbiny NM: Pramipexole protects against
diabetic neuropathy: effect on oxidative stress,
TLR4/IRAK-1/TRAF-6/NF-κB and downstream inflammatory mediators. Int
Immunopharmacol. 128:1115142024. View Article : Google Scholar
|
|
99
|
García-Rivera D, Delgado R, Bougarne N,
Haegeman G and Berghe WV: Gallic acid indanone and mangiferin
xanthone are strong determinants of immunosuppressive anti-tumour
effects of mangifera indica l. Bark in MDA-MB231 breast cancer
cells. Cancer Lett. 305:21–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Dai C, Yu L, Wang Z, Deng P, Li L, Gu Z,
He X, Wang J and Yuan J: Mangiferin and taurine ameliorate MSRV
infection by suppressing NF-κB signaling. Microbiol Spectr.
11:e05146222023. View Article : Google Scholar
|
|
101
|
Gálvez-Rodríguez A, Ferino-Pérez A,
Rodríguez-Riera Z, Rodeiro Guerra I, řeha D, Minofar B and
Jáuregui-Haza UJ: Explaining the interaction of mangiferin with
MMP-9 and NF-κβ: A computational study. J Mol Model. 28:2662022.
View Article : Google Scholar
|
|
102
|
Chen Q, Wang S, Bao R, Wang D, Wu Y, Zhang
Y, Liu M and Wang T: Combination of mangiferin and T0901317
targeting autophagy promotes cholesterol efflux from macrophage
foam cell in atherosclerosis. Chin Med. 19:52024. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zhu P, Liu C, Li B, Zhao C, Zhou T, Xue X
and Zhang B: Mangiferin attenuates IL-1β-induced chondrocytes
apoptosis. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 46:25–31. 2021.In
Chinese, English. PubMed/NCBI
|
|
104
|
Deng Q, Tian YX and Liang J: Mangiferin
inhibits cell migration and invasion through Rac1/WAVE2 signalling
in breast cancer. Cytotechnology. 70:593–601. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Shang HS, Chen CJ, Shih YL, Peng SF, Chen
YL, Liu KC, Huang HC, Hsueh SC, Chen KW, Lu HF, et al: Mangiferin
induces immune responses and evaluates the survival rate in WEHI-3
cell generated mouse leukemia in vivo. Environ Toxicol. 36:77–85.
2021. View Article : Google Scholar
|
|
106
|
Jeong JJ, Jang SE, Hyam SR, Han MJ and Kim
DH: Mangiferin ameliorates colitis by inhibiting IRAK1
phosphorylation in NF-κB and MAPK pathways. Eur J Pharmacol.
740:652–661. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Kammalla AK, Ramasamy MK, Inampudi J,
Dubey GP, Agrawal A and Kaliappan I: Comparative pharmacokinetic
study of mangiferin after oral administration of pure mangiferin
and US patented polyherbal formulation to rats. AAPS PharmSciTech.
16:250–258. 2015. View Article : Google Scholar :
|
|
108
|
Reddeman RA, Glávits R, Endres JR, Clewell
AE, Hirka GB, Vértesi A, Béres E and Szakonyiné IP: A toxicological
evaluation of mango leaf extract (mangifera indica) containing 60%
mangiferin. J Toxicol. 2019:47630152019. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zhang Q, Kong X, Yuan H, Guan H, Li Y and
Niu Y: Mangiferin improved palmitate-induced-insulin resistance by
promoting free fatty acid metabolism in HepG2 and c2c12 cells via
PPARα: mangiferin improved insulin resistance. J Diabetes Res.
2019:20526752019. View Article : Google Scholar
|
|
110
|
Jeyakodi S, Krishnakumar A, Dalal M and
Shetty BS: Assessment of efficacy and safety of mangifera indica
extract (stadice®) for cognitive function: A randomized,
double-blind, placebo-controlled study. Cureus. 16:e657512024.
|
|
111
|
Bulugonda RK, Kumar KA, Gangappa D, Beeda
H, Philip GH, Muralidhara Rao D and Faisal SM: Mangiferin from
pueraria tuberosa reduces inflammation via inactivation of NLRP3
inflammasome. Sci Rep. 7:426832017. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Jyotshna, Khare P and Shanker K:
Mangiferin: A review of sources and interventions for biological
activities. Biofactors. 42:504–514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Irshad N, Naeem H, Shahbaz M, Imran M,
Mujtaba A, Hussain M, Al Abdulmonem W, Alsagaby SA, Yehuala TF,
Abdelgawad MA, et al: Mangiferin: An effective agent against human
malignancies. Food Sci Nutr. 12:7137–7157. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Prado Y, Merino N, Acosta J, Herrera JA,
Luque Y, Hernández I, Prado E, Garrido G, Delgado R and Rodeiro I:
Acute and 28-day subchronic toxicity studies of mangiferin, a
glucosyl xanthone isolated from mangifera indica L. Stem bark. J
Pharm Pharmacogn Res. 3:13–23. 2015. View Article : Google Scholar
|
|
115
|
Feng ST, Wang ZZ, Yuan YH, Sun HM, Chen NH
and Zhang Y: Mangiferin: a multipotent natural product preventing
neurodegeneration in Alzheimer's and Parkinson's disease models.
Pharmacol Res. 146:1043362019. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Santonocito D, Vivero-Lopez M, Lauro MR,
Torrisi C, Castelli F, Sarpietro MG and Puglia C: Design of
nanotechnological carriers for ocular delivery of mangiferin:
Preformulation study. Molecules. 27:13282022. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Suchal K, Malik S, Khan SI, Malhotra RK,
Goyal SN, Bhatia J, Kumari S, Ojha S and Arya DS: Protective effect
of mangiferin on myocardial ischemia-reperfusion injury in
streptozotocin-induced diabetic rats: Role of AGE-RAGE/MAPK
pathways. Sci Rep. 7:420272017. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Espinosa-Espinosa L, Garduño-Siciliano L,
Rodriguez-Canales M, Hernandez-Portilla LB, Canales-Martinez MM and
Rodriguez-Monroy MA: The wound-healing effect of mango peel extract
on incision wounds in a murine model. Molecules. 27:2592022.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Pal PB, Sinha K and Sil PC: Mangiferin, a
natural xanthone, protects murine liver in Pb(II) induced hepatic
damage and cell death via MAP kinase, NF-κB and mitochondria
dependent pathways. PLoS One. 8:e568942013. View Article : Google Scholar
|
|
120
|
Chen X and Huang J: Mangiferin inhibits
hypoxia/reoxygenation-induced alveolar epithelial cell injury via
the SIRT1/AMPK signaling pathway. Exp Ther Med. 22:12202021.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Sadhukhan P, Saha S, Dutta S and Sil PC:
Mangiferin ameliorates cisplatin induced acute kidney injury by
upregulating Nrf-2 via the activation of PI3K and exhibits
synergistic anticancer activity with cisplatin. Front Pharmacol.
9:6382018. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Li W, Wang K, Liu Y, Wu H, He Y, Li C,
Wang Q, Su X, Yan S, Su W, et al: A novel drug combination of
mangiferin and cinnamic acid alleviates rheumatoid arthritis by
inhibiting TLR4/NFκB/NLRP3 activation-induced pyroptosis. Front
Immunol. 13:9129332022. View Article : Google Scholar
|
|
123
|
Radu AF and Bungau SG: Management of
rheumatoid arthritis: An overview. Cells. 10:28572021. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Yong Z, Ruiqi W, Hongji Y, Ning M, Chenzuo
J, Yu Z, Zhixuan X, Qiang L, Qibing L, Weiying L and Xiaopo Z:
Mangiferin ameliorates HFD-induced NAFLD through regulation of the
AMPK and NLRP3 inflammasome signal pathways. J Immunol Res.
2021:40845662021. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Wang H, Zhu YY, Wang L, Teng T, Zhou M,
Wang SG, Tian YZ, Du L, Yin XX and Sun Y: Mangiferin ameliorates
fatty liver via modulation of autophagy and inflammation in
high-fat-diet induced mice. Biomed Pharmacother. 96:328–335. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Li N, Xiong R, He R, Liu B, Wang B and
Geng Q: Mangiferin mitigates lipopolysaccharide-induced lung injury
by inhibiting NLRP3 inflammasome activation. J Inflamm Res.
14:2289–2300. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Saccà SC, Cutolo CA, Ferrari D, Corazza P
and Traverso CE: The eye, oxidative damage and polyunsaturated
fatty acids. Nutrients. 10:6682018. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Kim SJ, Sung MS, Heo H, Lee JH and Park
SWO: Mangiferin protects retinal ganglion cells in ischemic mouse
retina via SIRT1. Curr Eye Res. 41:844–855. 2016. View Article : Google Scholar
|
|
129
|
Fung TH, Patel B, Wilmot EG and Amoaku WM:
Diabetic retinopathy for the non-ophthalmologist. Clin Med (Lond).
22:112–116. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Shi J, Lv H, Tang C, Li Y, Huang J and
Zhang H: Mangiferin inhibits cell migration and angiogenesis via
PI3k/AKT/mTOR signaling in high glucose- and hypoxia-induced
RRCECs. Mol Med Rep. 23:4732021. View Article : Google Scholar :
|
|
131
|
Li X, Cui X, Wang J, Yang J, Sun X, Li X,
Zhu Q and Li W: Rhizome of Anemarrhena asphodeloides counteracts
diabetic ophthalmopathy progression in streptozotocin-induced
diabetic rats. Phytother Res. 27:1243–1250. 2013. View Article : Google Scholar
|
|
132
|
Hayes MT: Parkinson's disease and
parkinsonism. Am J Med. 132:802–807. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L,
Sun Y, Wu J, Zhou Q, Huang J, et al: Targeting microglial
α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's
disease. Front Immunol. 12:7198072021. View Article : Google Scholar
|
|
134
|
Chu YC, Yang CS, Cheng MJ, Fu SL and Chen
JJ: Comparison of various solvent extracts and major bioactive
components from unsalt-fried and salt-fried rhizomes of anemarrhena
asphodeloides for antioxidant, anti-α-glucosidase, and
anti-acetylcholinesterase activities. Antioxidants (Basel).
11:3852022. View Article : Google Scholar
|
|
135
|
Chen M, Wang Z, Zhou W, Lu C, Ji T, Yang
W, Jin Z, Tian Y, Lei W, Wu S, et al: SIRT1/PGC-1α signaling
activation by mangiferin attenuates cerebral hypoxia/reoxygenation
injury in neuroblastoma cells. Eur J Pharmacol. 907:1742362021.
View Article : Google Scholar
|
|
136
|
Arora MK, Kisku A and Jangra A: Mangiferin
ameliorates intracerebroventricular-quinolinic acid-induced
cognitive deficits, oxidative stress, and neuroinflammation in
wistar rats. Indian J Pharmacol. 52:296–305. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Liu T, Song Y and Hu A: Neuroprotective
mechanisms of mangiferin in neurodegenerative diseases. Drug Dev
Res. 82:494–502. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Du Z, Fanshi F, Lai YH, Chen JR, Hao E,
Deng J and Hsiao CD: Mechanism of anti-dementia effects of
mangiferin in a senescence accelerated mouse (SAMP8) model. Biosci
Rep. 39:BSR201904882019. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
López-Ríos L, Wiebe JC, Vega-Morales T and
Gericke N: Central nervous system activities of extract mangifera
indica L. J Ethnopharmacol. 260:1129962020. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Ho HJ and Shirakawa H: Oxidative stress
and mitochondrial dysfunction in chronic kidney disease. Cells.
12:882022. View Article : Google Scholar
|
|
141
|
Wang B, Wan J, Gong X, Kuang G, Cheng X
and Min S: Mangiferin attenuates renal ischemia-reperfusion injury
by inhibiting inflammation and inducing adenosine production. Int
Immunopharmacol. 25:148–154. 2015. View Article : Google Scholar
|
|
142
|
Zhang D, Han S, Zhou Y, Qi B and Wang X:
Therapeutic effects of mangiferin on sepsis-associated acute lung
and kidney injuries via the downregulation of vascular permeability
and protection of inflammatory and oxidative damages. Eur J Pharm
Sci. 152:1054002020. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Samsu N: Diabetic nephropathy: Challenges
in pathogenesis, diagnosis, and treatment. Biomed Res Int.
2021:14974492021. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Xu GK, Sun CY, Qin XY, Han Y, Li Y, Xie GY
and Min-Jian Q: Effects of ethanol extract of bombax ceiba leaves
and its main constituent mangiferin on diabetic nephropathy in
mice. Chin J Nat Med. 15:597–605. 2017.PubMed/NCBI
|
|
145
|
Wang X, Gao L, Lin H, Song J, Wang J, Yin
Y, Zhao J, Xu X, Li Z and Li L: Mangiferin prevents diabetic
nephropathy progression and protects podocyte function via
autophagy in diabetic rat glomeruli. Eur J Pharmacol. 824:170–178.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Chen L, Li S, Zhu J, You A, Huang X, Yi X
and Xue M: Mangiferin prevents myocardial infarction-induced
apoptosis and heart failure in mice by activating the Sirt1/FoxO3a
pathway. J Cell Mol Med. 25:2944–2955. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Han J, Yang N, Zhang F, Zhang C, Liang F,
Xie W and Chen W: Rhizoma anemarrhenae extract ameliorates
hyperglycemia and insulin resistance via activation of
AMP-activated protein kinase in diabetic rodents. J Ethnopharmacol.
172:368–376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Wang Y, Karmakar T, Ghosh N, Basak S and
Gopal Sahoo N: Targeting mangiferin loaded n-succinyl
chitosan-alginate grafted nanoparticles against atherosclerosis-a
case study against diabetes mediated hyperlipidemia in rat. Food
Chem. 370:1313762022. View Article : Google Scholar
|
|
149
|
Hou J, Zheng D, Fung G, Deng H, Chen L,
Liang J, Jiang Y and Hu Y: Mangiferin suppressed advanced glycation
end products (AGEs) through NF-κB deactivation and displayed
anti-inflammatory effects in streptozotocin and high fat
diet-diabetic cardiomyopathy rats. Can J Physiol Pharmacol.
94:332–340. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Zhao Y, Wang W, Wu X, Ma X, Qu R, Chen X,
Liu C, Liu Y, Wang X, Yan P, et al: Mangiferin antagonizes
TNF-α-mediated inflammatory reaction and protects against
dermatitis in a mice model. Int Immunopharmacol. 45:174–179. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Gunter NV, Teh SS, Lim YM and Mah SH:
Natural xanthones and skin inflammatory diseases: Multitargeting
mechanisms of action and potential application. Front Pharmacol.
11:5942022020. View Article : Google Scholar
|
|
152
|
Kumar M, Saurabh V, Tomar M, Hasan M,
Changan S, Sasi M, Maheshwari C, Prajapati U, Singh S, Prajapat RK,
et al: Mango (mangifera indica l.) Leaves: nutritional composition,
phytochemical profile, and health-promoting bioactivities.
Antioxidants (Basel). 10:2292021.
|
|
153
|
Ouf SA, Galal AMF, Ibrahim HS, Hassan AZ,
Mekhael MKG, El-Yasergy KF, El-Ghany MNA, Rizk MA and Hanna AG:
Phytochemical and antimicrobial investigation of the leaves of five
egyptian mango cultivars and evaluation of their essential oils as
preservatives materials. J Food Sci Technol. 58:3130–3142. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Saifi S, Ashraf A, Hasan GM, Shamsi A and
Hassan MI: Insights into the preventive actions of natural
compounds against klebsiella pneumoniae infections and drug
resistance. Fitoterapia. 173:1058112024. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Li H, Wang Q, Ding Y, Bao C and Li W:
Mangiferin ameliorates porphyromonas gingivalis-induced
experimental periodontitis by inhibiting phosphorylation of nuclear
factor-κB and janus kinase 1-signal transducer and activator of
transcription signaling pathways. J Periodontal Res. 52:1–7. 2017.
View Article : Google Scholar
|
|
156
|
Angusamy A, Balasubramanian V, Arunmurugan
B, Arunachalam K, Issac Abraham SVP, Murugesan S, Krishnasamy B,
Sundaram J and Arumugam VR: Anti-infective potential of
plant-derived quorum sensing inhibitors against multi-drug
resistant human and aquatic bacterial pathogens. World J Microbiol
Biotechnol. 39:1472023. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Ma H, Chen H, Sun L, Tong L and Zhang T:
Improving permeability and oral absorption of mangiferin by
phospholipid complexation. Fitoterapia. 93:54–61. 2014. View Article : Google Scholar
|
|
158
|
Pacheco-Ordaz RN, Antunes-Ricardo M,
Gutiérrez-Uribe JA and González-Aguilar GA: Intestinal permeability
and cellular antioxidant activity of phenolic compounds from mango
(mangifera indica cv. Ataulfo) peels. Int J Mol Sci. 19:5142018.
View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Hou S, Wang F, Li Y, Li Y, Wang M, Sun D
and Sun C: Pharmacokinetic study of mangiferin in human plasma
after oral administration. Food Chem. 132:289–294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Bunt D, Schwalbe M, Hayeeawaema F and El
Aidy S: Gut microbiota-mediated conversion of mangiferin to
norathyriol alters short chain fatty acid and urate metabolism. Gut
Microbes. 17:25084222025. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Barakat S, Nasr M, Ahmed RF, Badawy S and
Mortada N: Recent formulation advances of mangiferin. Rev Bras
Farmacogn. 32:871–882. 2022. View Article : Google Scholar
|
|
162
|
Guo X, Cheng M, Hu P, Shi Z, Chen S, Liu
H, Shi H, Xu Z, Tian X and Huang C: Absorption, metabolism, and
pharmacokinetics profiles of norathyriol, an aglycone of
mangiferin, in rats by HPLC-MS/MS. J Agric Food Chem.
66:12227–12235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Lin A, Li J, Li D, Jin H and Liu Y: Tissue
distribution study of mangiferin after intragastric administration
of mangiferin monomer, rhizoma anemarrhenae, and rhizoma
anemarrhenae-phellodendron decoctions in normal or type 2 diabetic
rats by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci.
1122-1123:18–28. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Al-Madhagi H: From nature to
nanotechnology: The bioactivities of mangiferin explored.
Nanotechnol Sci Appl. 18:277–294. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Shaikh I and Tatapudi HK: A review on
formulation and analytical aspect of mangiferin a natural phenolic
xanthonoid. Discov Chem. 2:1152025. View Article : Google Scholar
|
|
166
|
Fuentes-Rios D, Sanchez-Rodriguez A,
Lopez-Rios L, Garcia-Gonzalez E, Martinez-Canton M, Galvan-Alvarez
V, Gallego-Selles A, Martin-Rincon M, Calbet JAL and Vega-Morales
T: Human pharmacokinetic profiling and comparative analysis of
mangiferin and its monosodium derivative from mangifera indica
extracts using UHPLC-MS/MS with (1)h NMR and MALDI-TOF
confirmation. Molecules. 30:4612025. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Zhou H, Song S, Lan X, Li Y, Yuan X, Yang
J, Li M, Cao T and Zhang J: Comprehensive profiling of mangiferin
metabolites in vivo and in vitro based on the 'drug metabolite
clusters' analytical strategy. ACS Omega. 8:9934–9946. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
van der Merwe JD, Joubert E, Manley M, de
Beer D, Malherbe CJ and Gelderblom WCA: Mangiferin glucuronidation:
Important hepatic modulation of antioxidant activity. Food Chem
Toxicol. 50:808–815. 2012. View Article : Google Scholar
|
|
169
|
Souza JR, Trevisan MTS, Feitosa JP,
Ricardo NGM, Hull WE, Erben G, Würtele G, Breuer A, Frei E and
Ulrich CM: Transformation of mangiferin to norathyriol by human
fecal matrix in anaerobic conditions: Comprehensive NMR of the
xanthone metabolites, antioxidant capacity, and comparative
cytotoxicity against cancer cell lines. Nat Prod Commun. Mar
5–2020.Epub ahead of print.
|
|
170
|
Sarfraz M, Khan A, Batiha GE, Akhtar MF,
Saleem A, Ajiboye BO, Kamal M, Ali A, Alotaibi NM, Aaghaz S, et al:
Nanotechnology-based drug delivery approaches of mangiferin:
Promises, reality and challenges in cancer chemotherapy. Cancers
(Basel). 15:41942023. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Shaikenov RO, Klimshina VI, Morozkina SN
and Snetkov PP: Polymeric matrices for mangiferin delivery: Ways to
enhance bioavailability and therapeutic effect. Eng Proc.
87:782025.
|
|
172
|
Razura-Carmona FF, Pérez-Larios A,
González-Silva N, Herrera-Martínez M, Medina-Torres L,
Sáyago-Ayerdi SG and Sánchez-Burgos JA: Mangiferin-loaded polymeric
nanoparticles: Optical characterization, effect of
anti-topoisomerase I, and cytotoxicity. Cancers (Basel).
11:19652019. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Samadarsi R and Dutta D: Anti-oxidative
effect of mangiferin-chitosan nanoparticles on oxidative
stress-induced renal cells. Int J Biol Macromol. 151:36–46. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Zhang Y, Wang Y, Li X, Nie D, Liu C and
Gan Y: Ligand-modified nanocarriers for oral drug delivery:
Challenges, rational design, and applications. J Control Release.
352:813–832. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Ejazi SA, Louisthelmy R and Maisel K:
Mechanisms of nanoparticle transport across intestinal tissue: An
oral delivery perspective. ACS Nano. 17:13044–13061. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Wang H, Shao W, Lu X, Gao C, Fang L, Yang
X and Zhu P: Synthesis, characterization, and in vitro anti-tumor
activity studies of the hyaluronic acid-mangiferin-methotrexate
nanodrug targeted delivery system. Int J Biol Macromol.
239:1242082023. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Guo H, Chen M, Li M, Hu M, Chen B and Zhou
C: Pharmacokinetic comparisons of mangiferin and mangiferin
monosodium salt in rat plasma by UPLC-MS/MS. J Chem. Nov
14–2019.Epub ahead of print. View Article : Google Scholar
|
|
178
|
Lin H, Teng H, Wu W, Li Y, Lv G, Huang X,
Yan W and Lin Z: Pharmacokinetic and metabolomic analyses of
mangiferin calcium salt in rat models of type 2 diabetes and
non-alcoholic fatty liver disease. BMC Pharmacol Toxicol.
21:592020. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Faria M, Björnmalm M, Thurecht KJ, Kent
SJ, Parton RG, Kavallaris M, Johnston APR, Gooding JJ, Corrie SR,
Boyd BJ, et al: Minimum information reporting in bio-nano
experimental literature. Nat Nanotechnol. 13:777–785. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Sellamuthu PS, Muniappan BP, Perumal SM
and Kandasamy M: Antihyperglycemic effect of mangiferin in
streptozotocin induced diabetic rats. J Health Sci. 55:206–214.
2009. View Article : Google Scholar
|
|
181
|
Rodeiro I, José Gómez-Lechón M, Perez G,
Hernandez I, Herrera JA, Delgado R, Castell JV and Teresa Donato M:
Mangifera indica L. Extract and mangiferin modulate cytochrome p450
and UDP-glucuronosyltransferase enzymes in primary cultures of
human hepatocytes. Phytother Res. 27:745–752. 2013. View Article : Google Scholar
|
|
182
|
Sun D, Zhang CZ, Ran RX, Cao YF, Du Z, Fu
ZW, Huang CT, Zhao ZY, Zhang WH and Fang ZZ: In vitro comparative
study of the inhibitory effects of mangiferin and its aglycone
norathyriol towards UDP-glucuronosyl transferase (UGT) isoforms.
Molecules. 22:10082017. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Chieli E, Romiti N, Rodeiro I and Garrido
G: In vitro effects of mangifera indica and polyphenols derived on
ABCB1/p-glycoprotein activity. Food Chem Toxicol. 47:2703–2710.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Shang Y, Tian J, Zhang Z, Luo L, Saeheng
S, Qiu S, Zhou R, Chen J and Li L: Mangiferin: Sources,
anti-inflammatory activities, and molecular mechanisms. J Agric
Food Chem. 73:27145–27160. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Na L, Zhang Q, Jiang S, Du S, Zhang W, Li
Y, Sun C and Niu Y: Mangiferin supplementation improves serum lipid
profiles in overweight patients with hyperlipidemia: A double-blind
randomized controlled trial. Sci Rep. 5:103442015. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Peng ZG, Yao YB, Yang J, Tang YL and Huang
X: Mangiferin induces cell cycle arrest at G2/M phase through
ATR-Chk1 pathway in HL-60 leukemia cells. Genet Mol Res.
14:4989–5002. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Li J, Liu M, Yu H, Wang W, Han L, Chen Q,
Ruan J, Wen S, Zhang Y and Wang T: Mangiferin improves hepatic
lipid metabolism mainly through its metabolite-norathyriol by
modulating SIRT-1/AMPK/SREBP-1c signaling. Front Pharmacol.
9:2012018. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Bhatia J, Suchal K, Bhargava P, Malik S
and Arya D: Evaluation of the cardioprotective effect of mangiferin
in an experimental model of ischemia reperfusion injury. J
Hypertens. 39:e2802021. View Article : Google Scholar
|
|
189
|
Zivković J, Kumar KA, Rushendran R, Ilango
K, Fahmy NM, El-Nashar HAS, El-Shazly M, Ezzat SM, Melgar-Lalanne
G, Romero-Montero A, et al: Pharmacological properties of
mangiferin: Bioavailability, mechanisms of action and clinical
perspectives. Naunyn Schmiedebergs Arch Pharmacol. 397:763–781.
2024. View Article : Google Scholar
|
|
190
|
Ren K, Li H, Zhou HF, Liang Y, Tong M,
Chen L, Zheng XL and Zhao GJ: Mangiferin promotes macrophage
cholesterol efflux and protects against atherosclerosis by
augmenting the expression of ABCA1 and ABCG1. Aging (Albany NY).
11:10992–11009. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Minniti G, Laurindo LF, Machado NM, Duarte
LG, Guiguer EL, Araujo AC, Dias JA, Lamas CB, Nunes YC, Bechara MD,
et al: Mangifera indica L., By-products, and mangiferin on
cardio-metabolic and other health conditions: A systematic review.
Life (Basel). 13:22702023.PubMed/NCBI
|
|
192
|
Shen JM, Xu L, Lu Y, Cao HM, Xu ZG, Chen T
and Zhang HX: Chitosan-based luminescent/magnetic hybrid nanogels
for insulin delivery, cell imaging, and antidiabetic research of
dietary supplements. Int J Pharm. 427:400–409. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Khurana RK, Bansal AK, Beg S, Burrow AJ,
Katare OP, Singh KK and Singh B: Enhancing biopharmaceutical
attributes of phospholipid complex-loaded nanostructured lipidic
carriers of mangiferin: Systematic development, characterization
and evaluation. Int J Pharm. 518:289–306. 2017. View Article : Google Scholar
|
|
194
|
Zhao C, Pu Z, Gao J, Liu C, Xing J, Lang
W, Chen J, Yuan C and Zhou C: 'Multiomics' analyses combined with
systems pharmacology reveal the renoprotection of mangiferin
monosodium salt in rats with diabetic nephropathy: Focus on
improvements in renal ferroptosis, renal inflammation, and podocyte
insulin resistance. J Agric Food Chem. 71:358–381. 2023. View Article : Google Scholar
|
|
195
|
Vishwakarma KK, Hafeez A, Usmani SA, Noor
L and Khan IR: Nanocarrier-based delivery approaches of mangiferin:
an updated review on leveraging biopharmaceutical characteristics
of the bioactive. Curr Pharm Biotechnol. Sep 23–2024.Epub ahead of
print. PubMed/NCBI
|
|
196
|
Melo-Betances E, Rodríguez-Bautista CC and
Núñez-Sellés AJ: Synthesis of mangiferin derivatives, complexes,
and carriers as potential therapeutic candidates for cancer
treatment: An update. Front Pharmacol. 16:15987192025. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Wondrak GT: Redox-directed cancer
therapeutics: Molecular mechanisms and opportunities. Antioxid
Redox Signal. 11:3013–3069. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Li L, Dong Y, Liu X and Wang M: Mangiferin
for the management of liver diseases: A review. Foods. 12:24692023.
View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Mei S, Ma H and Chen X: Anticancer and
anti-inflammatory properties of mangiferin: A review of its
molecular mechanisms. Food Chem Toxicol. 149:1119972021. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
du Plessis-Stoman D, du Preez J and van de
Venter M: Combination treatment with oxaliplatin and mangiferin
causes increased apoptosis and downregulation of NFκB in cancer
cell lines. Afr J Tradit Complement Altern Med. 8:177–184.
2011.
|
|
201
|
Mu F, Liu T, Zheng H, Xie X, Lei T, He X,
Du S, Tong R and Wang Y: Mangiferin induces radiosensitization in
glioblastoma cells by inhibiting nonhomologous end joining. Oncol
Rep. 40:3663–3673. 2018.PubMed/NCBI
|
|
202
|
Wei Z, Yan L, Chen Y, Bao C and Deng J and
Deng J: Mangiferin inhibits macrophage classical activation via
downregulating interferon regulatory factor 5 expression. Mol Med
Rep. 14:1091–1098. 2016. View Article : Google Scholar : PubMed/NCBI
|
